Clinical Trial Update: Anti-protozoal Effect of Steroid Hormone 20-hydroxyecdysone [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating the anti-protozoal effects of the steroid hormone 20-hydroxyecdysone for Giardia lamblia infection. The study is currently active b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giardiasis

Drugs mentioned

• 20-hydroxyecdysone (20-hydroxyecdysone)

Snippet

Sponsor: Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan | Conditions: Giardia Lamblia Infection | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING